ESC 365 - Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study.

ESC Premium Access

Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study.

Session: Atrial fibrillation in hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor A. Foa' (Boston, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Alberto Foa'

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

0 follower

5 more presentations in this session

Efficacy and safety of non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy with non-valvular atrial fibrillation: a nationwide cohort study

Speaker: Doctor P. Yang (Seongnam, KR)

Left atrial remodelling in hypertrophic cardiomyopathy, contributing factors and associated outcomes

Speaker: Doctor S. Cuddy (Boston, US)

Impact of left atrial enlargement on very long-term outcomes in patients with hypertrophic cardiomyopathy

Speaker: Doctor Y. Azumi (Kobe, JP)

Is atrial fibrillation associated with increased mortality in hypertrophic cardiomyopathy? Results from the portuguese registry.

Speaker: Doctor A. Lebreiro (Porto, PT)

Atrial fibrillation in hypertrophic cardiomyopathy: clinical implications of an early detection through implanted cardioverter defibrillator

Speaker: Doctor R. Morgagni (Rome, IT)

Access the full session

Atrial fibrillation in hypertrophic cardiomyopathy

Speakers: Doctor A. Foa', Doctor P. Yang, Doctor S. Cuddy, Doctor Y. Azumi, Doctor A. Lebreiro...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources